Global patient safety and antiretroviral drug–drug interactions in the resource-limited setting

Seden, Kay; Khoo, Saye H.; Back, David; Byakika-Kibwika, Pauline; Lamorde, Mohammed; Ryan, Mairin; Merry, Concepta
January 2013
Journal of Antimicrobial Chemotherapy (JAC);Jan2013, Vol. 68 Issue 1, p1
Academic Journal
Scale-up of HIV treatment services may have contributed to an increase in functional health facilities available in resource-limited settings and an increase in patient use of facilities and retention in care. As more patients are reached with medicines, monitoring patient safety is increasingly important. Limited data from resource-limited settings suggest that medication error and antiretroviral drug–drug interactions may pose a significant risk to patient safety. Commonly cited causes of medication error in the developed world include the speed and complexity of the medication use cycle combined with inadequate systems and processes. In resource-limited settings, specific factors may contribute, such as inadequate human resources and high disease burden. Management of drug–drug interactions may be complicated by limited access to alternative medicines or laboratory monitoring. Improving patient safety by addressing the issue of antiretroviral drug–drug interactions has the potential not just to improve healthcare for individuals, but also to strengthen health systems and improve vital communication among healthcare providers and with regulatory agencies.


Related Articles

  • IS THE HUMAN LEUCOCYTE ANTIGEN B*5701 PREDICTED BY SEQUENCE VARIATIONS OF HIV-1 SUBTYPE F REVERSE TRANSCRIPTASE? Florea, D.; Oţelea, D.; Paraschiv, Simona; FrĐţilă, Mihaela; Streinu-Cercel, A. // Therapeutics, Pharmacology & Clinical Toxicology;2010, Vol. 14 Issue 3, p183 

    Objective: to evaluate the predictive value of mutations in position 245 of HIV reverse-transcriptase as a marker of the presence of HLA-B*5701 in HIV-1 subtype F1 infected patients. Methods: HIV drug resistance testing was performed by using the ViroSeq Genotyping System. Sequence-based HLA...

  • Treatment Options for HIV-Associated Tuberculosis. Onyebujoh, Philip Chukwuka; Ribeiro, Isabela; Whalen, Christopher Curtis // Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS35 

    The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ...

  • Assessment of hematological adverse drug reactions to antiretroviral therapy in HIV positive patients at Kasturba Hospital Manipal. Pulagam, Poornima; Rajesh, Radhakrishnan; Vidyasagar, Sudha; Varma, Danturulu Muralidhar // BMC Infectious Diseases;2012 Supplement, Vol. 12 Issue Supplment 1, p1 

    The article presents a study on the hematological adverse drug reactions (ADRs) associated with highly active antiretroviral therapy in HIV positive patients in India. The authors investigate the casuality, incidence rate and severity pattern of hematological ADRs among HIV patients. The study...

  • Influence of Adverse Drug Reactions on Treatment Success: Prospective Cohort Analysis of HIV-Infected Individuals Initiating First-Line Antiretroviral Therapy in India. Shet, Anita; Antony, Jimmy; Arumugam, Karthika; Kumar Dodderi, Sunil; Rodrigues, Rashmi; DeCosta, Ayesha // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Introduction: Adverse drug reactions related to antiretroviral therapy (ART) remain a challenge in resource-limited settings, often causing significant morbidity and impaired adherence leading to treatment failure. This 2-year prospective study aimed to describe patterns and predictors of...

  • Evaluation of the adverse reactions of antiretroviral drug regimens in a tertiary care hospital. Rather, Zahoor A.; Chowta, Mukta N.; Prakash Raju, G. J. K.; Mubeen, Faheem // Indian Journal of Pharmacology;Mar/Apr2013, Vol. 45 Issue 2, p145 

    Objectives: Antiretroviral toxicity is an increasingly important issue in the management of HIV-infected patients. The objective of our study was to evaluate the toxicity profile of currently used antiretroviral regimens and to compare these toxicities among males and females. Materials and...

  • Metabolic Effects of Rosiglitazone in HIV Lipodystrophy. Hadigan, Colleen; Yawetz, Sigal; Thomas, Abraham; Havers, Fiona; Sax, Paul E.; Grinspoon, Steven // Annals of Internal Medicine;5/18/2004, Vol. 140 Issue 10, p786 

    Background: Patients with HIV infection who are treated with antiretroviral agents often lose subcutaneous fat and have metabolic abnormalities, including insulin resistance and reduced adiponectin levels, which may be related to disrupted subcutaneous adipogenesis and altered peroxisome...

  • In Vitro Inhibitory Effects of the Herbal-Marine Compound HESA-A Against Replication of Human Immunodeficiency Virus-1. Vahabpour, Rouhollah; Sadat, Seyed Mehdi; Zabihollahi, Rezvan; Ahmadi, Amrollah; Keivani, Hossein; Amini, Safieh; Siadat, Seyed Davar; Aghasadeghi, Mohammad Reza // Jundishapur Journal of Microbiology;2012, Vol. 5 Issue 1, p315 

    Background: For more than 2 decades, human immunodeficiency virus (HIV) infection has been known to cause significant morbidity and mortality. Difficulties in treating HIV-infected patients include adverse effects and drug resistance and continue to limit the use of conventional anti-retroviral...

  • Where to Start?  // Guide;May2006, Vol. 26 Issue 5, p77 

    The article states that the use of antiretroviral therapy for HIV patients still faces challenges, such as major adverse effects, difficulties of patients to comply with treatment regimen, and antiretroviral drug resistance. Patients are encouraged to visit www.hivinsite.org to obtain...

  • Structured Intermittent Therapy with Seven-Day Cycles of HAART for Chronic HIV Infection: A Pilot Study in São Paulo, Brazil. Casseb, Jorge; Da Silva Duarte, Alberto Jos // AIDS Patient Care & STDs;Jul2005, Vol. 19 Issue 7, p425 

    In the last 6 years, an impressive impact of the highly active antiretroviral therapy (HAART) on survival and morbidity in HIV-1–infected individuals has been attained. However, their prolonged use may induce metabolic adverse effects such as lipodistrophy, hypertension, diabetes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics